Pfizer Inc (PFE)
29.11USD
1 Aug 2013
$-0.12 (-0.41%)
$29.23
$29.43
$29.45
$28.98
31,632,654
61,362,894
$31.15
$23.55
About
Overall
| Beta: | 0.73 |
| Market Cap (Mil.): | $207,334.91 |
| Shares Outstanding (Mil.): | 7,093.22 |
| Dividend: | 0.24 |
| Yield (%): | 3.28 |
Financials
| PFE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 19.88 | 37.93 | 37.76 |
| EPS (TTM): | 1.47 | -- | -- |
| ROI: | -- | 19.48 | 18.76 |
| ROE: | -- | 20.17 | 19.59 |
US STOCKS-S&P 500, Nasdaq end up as tech gains; potash shares sink
* Mosaic, Potash Corp sink after Russia quits top potash cartel
Pfizer settles U.S. marketing case related to Rapamune
WASHINGTON - Pfizer Inc will pay $490.9 million to resolve accusations of illegal marketing of the drug Rapamune dating to Pfizer's 2009 acquisition of Wyeth Pharmaceuticals Inc, the U.S. Justice Department said on Tuesday.
UPDATE 1-Pfizer settles U.S. marketing case related to Rapamune
WASHINGTON, July 30 - Pfizer Inc will pay $490.9 million to resolve accusations of illegal marketing of the drug Rapamune dating to Pfizer's 2009 acquisition of Wyeth Pharmaceuticals Inc, the U.S. Justice Department said on Tuesday.
Cost controls help Pfizer, Merck weather weak quarter
- Big Pharma is still relying on belt-tightening to prop up financial results.
WRAPUP 1-Cost controls help Pfizer, Merck weather weak quarter
July 30 - Big Pharma is still relying on belt-tightening to prop up financial results.
US STOCKS-Wall St rises on earnings; potash selloff reins in S&P
* Mosaic, Potash Corp sink after Russia quits top potash cartel
US STOCKS-Wall Street rises on earnings; potash cos down
* Mosaic, Potash Corp tumble after Russia quits top potash cartel
US STOCKS-Futures tick higher ahead of data, Fed in focus
* Mosaic, Potash Corp tumble after Russia quits top potash cartel
Pfizer earnings top estimates, reiterates forecast
- Pfizer Inc reported second-quarter earnings slightly ahead of estimates on Tuesday as the largest U.S. drugmaker lines up a business split that could lead to the spinoff of its generics division.
REFILE-US STOCKS-Futures tick higher before data, Fed in focus
* Mosaic, Potash Corp tumble after Russia quits top potash cartel
Competitors
| Price | Change | |
|---|---|---|
| The Procter & Gamble Company (PG.N) | $81.64 | +1.34 |
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Merck & Co., Inc. (MRK.N) | $48.58 | +0.41 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Bayer AG (BAYGn.DE) | €89.43 | +2.08 |
| Bayer AG (BAYE.F) | -- | -- |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| AstraZeneca plc (AZN.L) | 3,334.00p | -1.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

